Stokoe D - Search Results

1

Biomarkers to predict response to epidermal growth factor receptor inhibitors.

Haas-Kogan DA, Prados MD, Lamborn KR, Tihan T, Berger MS, Stokoe D. Haas-Kogan DA, et al. Among authors: stokoe d. Cell Cycle. 2005 Oct;4(10):1369-72. doi: 10.4161/cc.4.10.2105. Epub 2005 Oct 17. Cell Cycle. 2005. PMID: 16177570

2

Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.

Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk AR, Nicholas MK, Stokoe D, Haas-Kogan DA. Ermoian RP, et al. Among authors: stokoe d. Clin Cancer Res. 2002 May;8(5):1100-6. Clin Cancer Res. 2002. PMID: 12006525

3

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.

Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D. Haas-Kogan DA, et al. Among authors: stokoe d. J Natl Cancer Inst. 2005 Jun 15;97(12):880-7. doi: 10.1093/jnci/dji161. J Natl Cancer Inst. 2005. PMID: 15956649 Clinical Trial.

4

PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.

Nakamura JL, Karlsson A, Arvold ND, Gottschalk AR, Pieper RO, Stokoe D, Haas-Kogan DA. Nakamura JL, et al. Among authors: stokoe d. J Neurooncol. 2005 Feb;71(3):215-22. doi: 10.1007/s11060-004-1718-y. J Neurooncol. 2005. PMID: 15735908

5

Inhibition of phosphatidylinositol-3-kinase causes cell death through a protein kinase B (PKB)-dependent mechanism and growth arrest through a PKB-independent mechanism.

Gottschalk AR, Doan A, Nakamura JL, Haas-Kogan DA, Stokoe D. Gottschalk AR, et al. Among authors: stokoe d. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1183-8. doi: 10.1016/j.ijrobp.2004.12.024. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752900

6

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS. Mellinghoff IK, et al. Among authors: stokoe d. N Engl J Med. 2005 Nov 10;353(19):2012-24. doi: 10.1056/NEJMoa051918. N Engl J Med. 2005. PMID: 16282176 Free article.

7

Glucose withdrawal induces oxidative stress followed by apoptosis in glioblastoma cells but not in normal human astrocytes.

Jelluma N, Yang X, Stokoe D, Evan GI, Dansen TB, Haas-Kogan DA. Jelluma N, et al. Among authors: stokoe d. Mol Cancer Res. 2006 May;4(5):319-30. doi: 10.1158/1541-7786.MCR-05-0061. Mol Cancer Res. 2006. PMID: 16687487

8

Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.

Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, Stokoe D. Wiencke JK, et al. Among authors: stokoe d. Neuro Oncol. 2007 Jul;9(3):271-9. doi: 10.1215/15228517-2007-003. Epub 2007 May 15. Neuro Oncol. 2007. PMID: 17504928 Free PMC article.

9

Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma.

Chen JS, Zhou LJ, Entin-Meer M, Yang X, Donker M, Knight ZA, Weiss W, Shokat KM, Haas-Kogan D, Stokoe D. Chen JS, et al. Among authors: stokoe d. Mol Cancer Ther. 2008 Apr;7(4):841-50. doi: 10.1158/1535-7163.MCT-07-0393. Mol Cancer Ther. 2008. PMID: 18413797

10

PTEN in brain tumors.

Haas-Kogan D, Stokoe D. Haas-Kogan D, et al. Among authors: stokoe d. Expert Rev Neurother. 2008 Apr;8(4):599-610. doi: 10.1586/14737175.8.4.599. Expert Rev Neurother. 2008. PMID: 18416662 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page